- Home
- BKYI vs TRIB Comparison
BKYI vs TRIB Comparison
Compare BKYI & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- TRIB
- Stock Information
- Founded
- BKYI 1993
- TRIB 1992
- Country
- BKYI United States
- TRIB Ireland
- Employees
- BKYI N/A
- TRIB N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BKYI Technology
- TRIB Health Care
- Exchange
- BKYI Nasdaq
- TRIB Nasdaq
- Market Cap
- BKYI 5.3M
- TRIB 5.4M
- IPO Year
- BKYI 1997
- TRIB N/A
- Fundamental
- Price
- BKYI $0.75
- TRIB $1.07
- Analyst Decision
- BKYI
- TRIB
- Analyst Count
- BKYI 0
- TRIB 0
- Target Price
- BKYI N/A
- TRIB N/A
- AVG Volume (30 Days)
- BKYI 139.1K
- TRIB 109.3K
- Earning Date
- BKYI 11-13-2025
- TRIB 11-14-2025
- Dividend Yield
- BKYI N/A
- TRIB N/A
- EPS Growth
- BKYI N/A
- TRIB N/A
- EPS
- BKYI N/A
- TRIB N/A
- Revenue
- BKYI $6,911,148.00
- TRIB $61,555,000.00
- Revenue This Year
- BKYI $7.45
- TRIB $13.51
- Revenue Next Year
- BKYI $23.29
- TRIB $13.14
- P/E Ratio
- BKYI N/A
- TRIB N/A
- Revenue Growth
- BKYI N/A
- TRIB 8.31
- 52 Week Low
- BKYI $0.52
- TRIB $0.48
- 52 Week High
- BKYI $3.68
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- BKYI 46.17
- TRIB 44.32
- Support Level
- BKYI $0.71
- TRIB $1.00
- Resistance Level
- BKYI $0.81
- TRIB $1.17
- Average True Range (ATR)
- BKYI 0.04
- TRIB 0.07
- MACD
- BKYI 0.00
- TRIB -0.01
- Stochastic Oscillator
- BKYI 35.10
- TRIB 27.96
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.